Indian generic pharmaceutical trading
WHO-GMP and PIC/S certified supply network
Active in Southeast Asia and CIS — expanding to Middle East

Your next supply partner
already knows
your market.

While others arrive with a catalogue, Aravis arrives having mapped your market, identified portfolio gaps, and prepared documentation-ready proposals — before the first conversation.

Know the market.
Grow Scroll to explore

The gap between what a market needs and what it receives is a sourcing problem. Aravis solves it before it becomes one.

Therapy areas

Three lead areas. Documentation depth across each.

Every molecule we propose is backed by technical documentation compiled to the regulatory standard of your market — the filing work is done before the commercial conversation begins.

View full portfolio →
Registered
Documentation ready
Under registration

How we work

The work happens before the meeting.

Manufacturing

WHO-GMP and PIC/S certified supply across four dosage forms.

Markets

Active markets. Honest about where we are.

We operate in markets where we have named distribution partners, active registrations, and filed dossiers. We do not list markets we are exploring as markets we are in.

We are selective about
who we work with.
So are you.

We review all enquiries and respond within 48 hours where there is portfolio fit.